Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture

NCT02475187 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2021-04-15

No results posted yet for this study

Summary

Measurement of thrombogenic properties by TEG and MEA and observation of thrombotic events over 2 years in 220 patients with hip fracture.

Conditions

  • Thromboembolism

Sponsors & Collaborators

  • Vestre Viken Hospital Trust

    lead OTHER

Principal Investigators

  • Øystein Meen, Phd · Kongsberg Hospital, Vestre Viken Hospital trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-02-01
Completion
2018-02-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02475187 on ClinicalTrials.gov